Novo Nordisk Aktie
WKN: 866931 / ISIN: US6701002056
05.07.2024 11:50:00
|
Is It Too Late to Buy Novo Nordisk Stock?
Most investors would love a stock that delivers a 76% return over three years. Novo Nordisk (NYSE: NVO) has done it over the last 12 months.However, the most crucial factor for evaluating a stock is not its past performance but rather its potential future performance. Is it too late to buy Novo Nordisk stock?One main knock against Novo Nordisk is its steep valuation. The stock trades at over 43 times forward earnings. By comparison, the average forward earnings multiple for the S&P 500 healthcare sector is under 19.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novo Nordisk (spons. ADRs)mehr Nachrichten
Analysen zu Novo Nordisk (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Novo Nordisk (spons. ADRs) | 63,40 | -0,94% |
|